| scholarly article | Q13442814 |
| P2093 | author name string | Marie-France Penet | |
| Zaver M Bhujwalla | |||
| Dmitri Artemov | |||
| Sudath Hapuarachchige | |||
| Zhihang Chen | |||
| Samata Kakkad | |||
| Jiefu Jin | |||
| P2860 | cites work | "One-for-All"-Type, Biodegradable Prussian Blue/Manganese Dioxide Hybrid Nanocrystal for Trimodal Imaging-Guided Photothermal Therapy and Oxygen Regulation of Breast Cancer. | Q38856837 |
| Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles | Q38873993 | ||
| Controlled internalization of Her-2/ neu receptors by cross-linking for targeted delivery | Q40036475 | ||
| Multimodal image-guided enzyme/prodrug cancer therapy | Q40206021 | ||
| In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging. | Q40477559 | ||
| Anti-tumor effects and lack of side effects in mice of an immunotoxin directed against human and mouse prostate-specific membrane antigen | Q40529779 | ||
| Molecular MR imaging of fibrosis in a mouse model of pancreatic cancer. | Q41388169 | ||
| Hyperpolarized 1-[13C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Androgen Ablation Therapy in Prostate Cancer | Q44942509 | ||
| A Novel Theranostic Strategy for MMP-14-Expressing Glioblastomas Impacts Survival. | Q45966683 | ||
| Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate | Q46570233 | ||
| Acid-degradable Dextran as an Image Guided siRNA Carrier for COX-2 Downregulation. | Q47106820 | ||
| A Laser-Activated Biocompatible Theranostic Nanoagent for Targeted Multimodal Imaging and Photothermal Therapy | Q47127845 | ||
| Synthesis and Assessment of Peptide Gd-DOTA Conjugates Targeting Extradomain B Fibronectin for Magnetic Resonance Molecular Imaging of Prostate Cancer | Q47602413 | ||
| A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects. | Q48106124 | ||
| Redox-responsive dextran based theranostic nanoparticles for near-infrared/magnetic resonance imaging and magnetically targeted photodynamic therapy | Q48168073 | ||
| CEST MRI of 3-O-methyl-D-glucose on different breast cancer models | Q48651206 | ||
| Proteoglycans remodeling in cancer: Underlying molecular mechanisms. | Q50058046 | ||
| High response rate to PD-1 blockade in desmoplastic melanomas | Q50103620 | ||
| Controllable synthesis of dual-MOFs nanostructures for pH-responsive artemisinin delivery, magnetic resonance and optical dual-model imaging-guided chemo/photothermal combinational cancer therapy. | Q51312299 | ||
| In vivo MRI tracking of exogenous monocytes/macrophages targeting brain tumors in a rat model of glioma | Q81164931 | ||
| In vivo tumor diagnosis and photodynamic therapy via tumoral pH-responsive polymeric micelles | Q84561321 | ||
| Enhanced delivery of nano- and submicron particles using elongated microparticles | Q85225570 | ||
| HER-2-positive metastatic breast cancer: trastuzumab and beyond | Q94706721 | ||
| Dynamic Glucose-Enhanced (DGE) MRI: Translation to Human Scanning and First Results in Glioma Patients | Q27342287 | ||
| Hypoxic tumor environments exhibit disrupted collagen I fibers and low macromolecular transport | Q28537591 | ||
| CEST theranostics: label-free MR imaging of anticancer drugs | Q28833807 | ||
| First clinical experience with a dedicated MRI-guided high-intensity focused ultrasound system for breast cancer ablation. | Q30372040 | ||
| Low Dose Focused Ultrasound Induces Enhanced Tumor Accumulation of Natural Killer Cells | Q30398870 | ||
| Dawn of advanced molecular medicine: nanotechnological advancements in cancer imaging and therapy | Q30421668 | ||
| Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular Imaging | Q30851553 | ||
| Collagen fibers mediate MRI-detected water diffusion and anisotropy in breast cancers | Q31136665 | ||
| Design of Tumor Acidity-Responsive Sheddable Nanoparticles for Fluorescence/Magnetic Resonance Imaging-Guided Photodynamic Therapy | Q33588234 | ||
| PSMA-targeted theranostic nanoplex for prostate cancer therapy. | Q33791366 | ||
| Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2. | Q34159304 | ||
| Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapy | Q34348175 | ||
| Choline metabolism in malignant transformation | Q35112040 | ||
| MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles | Q35196287 | ||
| A protein therapeutic modality founded on molecular regulation. | Q35239717 | ||
| Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug | Q35585226 | ||
| Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles | Q35832224 | ||
| Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats | Q36125194 | ||
| The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy | Q36689474 | ||
| Bioorthogonal two-component drug delivery in HER2(+) breast cancer mouse models. | Q36789848 | ||
| Ovarian carcinoma: quantitative biexponential MR imaging relaxometry reveals the dynamic recruitment of ferritin-expressing fibroblasts to the angiogenic rim of tumors. | Q37113270 | ||
| The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies | Q37326072 | ||
| Nanotechnology in medical imaging: probe design and applications. | Q37341362 | ||
| Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues | Q37543916 | ||
| Assessing Oxidative Stress in Tumors by Measuring the Rate of Hyperpolarized [1-13C]Dehydroascorbic Acid Reduction Using 13C Magnetic Resonance Spectroscopy | Q37623373 | ||
| Exploiting the tumor microenvironment for theranostic imaging | Q37906480 | ||
| Current mechanistic insights into the roles of matrix metalloproteinases in tumour invasion and metastasis | Q38547173 | ||
| Compressed sensing for body MRI. | Q38782179 | ||
| Tumor Angiogenesis Targeted Radiosensitization Therapy Using Gold Nanoprobes Guided by MRI/SPECT Imaging | Q38806482 | ||
| PSMA-specific theranostic nanoplex for combination of TRAIL gene and 5-FC prodrug therapy of prostate cancer. | Q38808957 | ||
| P304 | page(s) | 141-151 | |
| P577 | publication date | 2018-04-26 | |
| P1433 | published in | Journal of Magnetic Resonance | Q3186925 |
| P1476 | title | Theranostics and metabolotheranostics for precision medicine in oncology | |
| P478 | volume | 291 |
| Q90322125 | The Local Atomic Structure of Colloidal Superparamagnetic Iron Oxide Nanoparticles for Theranostics in Oncology | cites work | P2860 |
Search more.